Importantly, most prior reviews have focused on populations with diabetes, leaving knowledge gaps regarding the relative benefits of GLP-1 RAs in non-diabetic patients with obesity. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.